ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,111.05
0.32%
Dow Jones
43,408.47
0.00%
Gold vs US Dollar
2,664.59
0.46%
Brent Oil
73.855
1.39%
Bitcoin
97,483.87
3.31%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adverum Biotechnologies Inc (ADVM)

  7. Adverum Biotechnologies Inc (ADVM) News

Adverum Biotechnologies (ADVM)

Adverum Biotechnologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADVM
DateTimeSourceHeadlineSymbolCompany
20/11/202421:05GlobeNewswire Inc.Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ADVMAdverum Biotechnologies Inc
18/11/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
18/11/202412:00GlobeNewswire Inc.Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design ElementsNASDAQ:ADVMAdverum Biotechnologies Inc
15/11/202421:05GlobeNewswire Inc.Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design ElementsNASDAQ:ADVMAdverum Biotechnologies Inc
14/11/202423:57Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ADVMAdverum Biotechnologies Inc
14/11/202423:40Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ADVMAdverum Biotechnologies Inc
14/11/202421:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ADVMAdverum Biotechnologies Inc
08/11/202419:17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ADVMAdverum Biotechnologies Inc
04/11/202421:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADVMAdverum Biotechnologies Inc
04/11/202421:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
04/11/202421:39GlobeNewswire Inc.Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated MilestonesNASDAQ:ADVMAdverum Biotechnologies Inc
31/10/202401:34Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ADVMAdverum Biotechnologies Inc
23/10/202417:34Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ADVMAdverum Biotechnologies Inc
22/10/202422:06Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ADVMAdverum Biotechnologies Inc
16/10/202412:00GlobeNewswire Inc.Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal ProgramNASDAQ:ADVMAdverum Biotechnologies Inc
05/09/202411:30GlobeNewswire Inc.Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ADVMAdverum Biotechnologies Inc
04/09/202420:05GlobeNewswire Inc.Adverum Biotechnologies to Participate in Upcoming Fall Investor ConferencesNASDAQ:ADVMAdverum Biotechnologies Inc
12/08/202420:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADVMAdverum Biotechnologies Inc
12/08/202420:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
12/08/202420:05GlobeNewswire Inc.Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate HighlightsNASDAQ:ADVMAdverum Biotechnologies Inc
06/08/202420:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADVMAdverum Biotechnologies Inc
06/08/202420:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADVMAdverum Biotechnologies Inc
06/08/202420:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADVMAdverum Biotechnologies Inc
02/08/202411:00GlobeNewswire Inc.Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:ADVMAdverum Biotechnologies Inc
01/08/202412:00GlobeNewswire Inc.Adverum Biotechnologies Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for Ixo-vec for the Treatment of Wet AMDNASDAQ:ADVMAdverum Biotechnologies Inc
17/07/202420:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
17/07/202406:45GlobeNewswire Inc.Adverum Biotechnologies Presents Positive Ixo-vec Clinical Data from the 26-Week Interim Analysis of the LUNA Phase 2 Trial at the 2024 ASRS Annual MeetingNASDAQ:ADVMAdverum Biotechnologies Inc
10/07/202412:00GlobeNewswire Inc.Adverum Biotechnologies to Host Webcast to Review Clinical Data from the 26-Week Interim Analysis of the Ongoing LUNA Phase 2 Trial in Wet AMD Being Presented at ASRS Annual MeetingNASDAQ:ADVMAdverum Biotechnologies Inc
18/06/202420:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADVMAdverum Biotechnologies Inc
18/06/202412:00GlobeNewswire Inc.Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA SummitNASDAQ:ADVMAdverum Biotechnologies Inc
 Showing the most relevant articles for your search:NASDAQ:ADVM

Your Recent History

LSE
DEC
Diversified Energy
LSE
VAST
Vast Resources
LSE
SYME
Supply@me Capital
LSE
LIO
Liontrust Asset Management
LSE
POS
Plexus
LSE
STX
Shield Therapeutics
LSE
MIN
Minoan
LSE
ITM
Itm Power
LSE
GGP
Greatland Gold
LSE
AAZ
Anglo Asian Mining
LSE
LLOY
Lloyds Banking
LSE
TERN
Tern
LSE
NEXN
Nexxen
LSE
POLX
Polarean Imaging
LSE
NESF
Nextenergy Solar
LSE
JD.
Jd Sports Fashion
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06